Suppr超能文献

慢性阻塞性肺疾病急性加重期治疗过程中氧化/抗氧化失衡的减轻

Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease.

作者信息

Rahman I, Skwarska E, MacNee W

机构信息

Department of Medicine, Royal Infirmary, Edinburgh, UK.

出版信息

Thorax. 1997 Jun;52(6):565-8. doi: 10.1136/thx.52.6.565.

Abstract

BACKGROUND

An oxidant/antioxidant imbalance is thought to occur in patients with chronic obstructive pulmonary disease (COPD). It has recently been shown that during exacerbations of COPD the antioxidant capacity and protein sulfhydryls of plasma are lower and the levels of products of lipid peroxidation are higher than in age matched healthy subjects. The aims of this study were to confirm these data and to measure the time course of these changes.

METHODS

The plasma Trolox equivalent antioxidant capacity (TEAC), protein sulfhydryls, and products of lipid peroxidation were measured throughout the course of treatment in 13 patients who presented with an acute exacerbation of COPD.

RESULTS

TEAC values (mmol/l) were low on admission (mean 0.67, 95% confidence interval (CI) 0.32 to 0.88; p < 0.05) and had increased by discharge (0.98, 95% CI 0.88 to 1.2; p < 0.05) but still remained lower than in healthy subjects (1.33, 95% CI 1.11 to 1.65). There was also restoration of plasma protein sulfhydryl levels (mmol/l) from admission (0.32, 95% CI 0.20 to 0.43) to discharge (0.49, 95% CI 0.42 to 0.62, p < 0.001) to levels similar to those in healthy subjects (0.52, 95% CI 0.43 to 0.65). Products of lipid peroxidation, measured as thiobarbituric acid-malondialdehyde adducts (mumol/l), were significantly higher (2.08, 95% CI 1.8 to 2.5) than in control subjects (1.3, 95% CI 0.85 to 1.32; p < 0.01) and returned to normal values by the time of discharge (1.2, 95% CI 0.88 to 1.29).

CONCLUSIONS

These data confirm the presence of a profound oxidant/antioxidant imbalance in the blood of patients with acute exacerbations of COPD which returns towards normal values during the course of treatment.

摘要

背景

氧化应激/抗氧化失衡被认为发生在慢性阻塞性肺疾病(COPD)患者中。最近研究表明,在COPD急性加重期,患者血浆抗氧化能力和蛋白质巯基水平低于年龄匹配的健康受试者,脂质过氧化产物水平则高于健康受试者。本研究旨在证实这些数据,并测定这些变化的时间进程。

方法

对13例COPD急性加重期患者在整个治疗过程中测定血浆特洛克斯等效抗氧化能力(TEAC)、蛋白质巯基和脂质过氧化产物水平。

结果

入院时TEAC值(mmol/L)较低(均值0.67,95%置信区间(CI)0.32至0.88;p<0.05),出院时升高(0.98,95%CI 0.88至1.2;p<0.05),但仍低于健康受试者(1.33,95%CI 1.11至1.65)。血浆蛋白质巯基水平(mmol/L)也从入院时(0.32,95%CI 0.20至0.43)恢复至出院时(0.49,95%CI 0.42至0.62,p<0.001),与健康受试者水平(0.52,95%CI 0.43至0.65)相似。以硫代巴比妥酸-丙二醛加合物(μmol/L)衡量的脂质过氧化产物水平显著高于对照组(2.08,95%CI 1.8至2.5)(对照组为1.3,95%CI 0.85至1.32;p<0.01),出院时恢复至正常水平(1.2,95%CI 0.88至1.29)。

结论

这些数据证实了COPD急性加重期患者血液中存在严重的氧化应激/抗氧化失衡,且在治疗过程中趋于恢复正常水平。

相似文献

2
Systemic oxidative stress in asthma, COPD, and smokers.
Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1055-60. doi: 10.1164/ajrccm.154.4.8887607.
4
Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis.
Free Radic Biol Med. 1999 Jul;27(1-2):60-8. doi: 10.1016/s0891-5849(99)00035-0.
8
Evaluation of the oxidant and antioxidant balance in the pathogenesis of chronic obstructive pulmonary disease.
Rev Port Pneumol. 2013 Mar-Apr;19(2):70-5. doi: 10.1016/j.rppneu.2012.09.002. Epub 2012 Nov 29.
9
Altered oxidant-antioxidant levels in the disease prognosis of chronic obstructive pulmonary disease.
Int J Tuberc Lung Dis. 2013 Aug;17(8):1104-9. doi: 10.5588/ijtld.12.0512.
10

引用本文的文献

1
Prescription patterns and symptom relief of antitussives and expectorants in patients with cough: a nationwide study in Korea.
J Thorac Dis. 2024 Sep 30;16(9):6150-6160. doi: 10.21037/jtd-23-1744. Epub 2024 Sep 3.
2
How and when to manage respiratory infections out of hospital.
Eur Respir Rev. 2022 Oct 19;31(166). doi: 10.1183/16000617.0092-2022. Print 2022 Dec 31.
3
as Add-On Therapy for COPD Patients: A Randomized, Placebo-Controlled, Double-Blind Study.
Front Pharmacol. 2022 Jun 16;13:901710. doi: 10.3389/fphar.2022.901710. eCollection 2022.
5
Total Antioxidant Status in Stable Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2020 Oct 6;15:2411-2419. doi: 10.2147/COPD.S264944. eCollection 2020.
6
Reliability and Usefulness of Different Biomarkers of Oxidative Stress in Chronic Obstructive Pulmonary Disease.
Oxid Med Cell Longev. 2020 May 14;2020:4982324. doi: 10.1155/2020/4982324. eCollection 2020.
9
Comprehensive evidence-based review on European antitussives.
BMJ Open Respir Res. 2016 Aug 5;3(1):e000137. doi: 10.1136/bmjresp-2016-000137. eCollection 2016.
10
Impaired neutrophil directional chemotactic accuracy in chronic periodontitis patients.
J Clin Periodontol. 2015 Jan;42(1):1-11. doi: 10.1111/jcpe.12326. Epub 2015 Jan 8.

本文引用的文献

1
Systemic oxidative stress in asthma, COPD, and smokers.
Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):1055-60. doi: 10.1164/ajrccm.154.4.8887607.
2
Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease.
Thorax. 1996 Apr;51(4):348-50. doi: 10.1136/thx.51.4.348.
5
Fibrin and cancer.
Thromb Haemost. 1993 May 3;69(5):406-14.
6
Evaluating prethrombotic state in lung cancer using molecular markers.
Chest. 1993 Jan;103(1):196-200. doi: 10.1378/chest.103.1.196.
8
Determination of carbonyl content in oxidatively modified proteins.
Methods Enzymol. 1990;186:464-78. doi: 10.1016/0076-6879(90)86141-h.
9
Noninvasive measures of oxidative stress status in humans.
Free Radic Biol Med. 1991;10(3-4):177-84. doi: 10.1016/0891-5849(91)90073-c.
10
Coagulation abnormalities in malignancy: a review.
Semin Thromb Hemost. 1992;18(4):353-72. doi: 10.1055/s-2007-1002575.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验